Why Neovasc's Stock Is Trading Higher Today

Neovasc NCVN shares are trading higher after the company regained compliance with the Nasdaq minimum bid price rule.

Neovasc Inc is a specialty medical device company. The company develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Tiara for the transcatheter treatment of mitral valve disease and the Neovasc Reducer for the treatment of refractory angina. Neovasc is developing the Tiara for the treatment of mitral valve disease.

Neovasc stock was up 37.16% at $2.03. The stock has a 52-week high of $3.88 and a 52-week low of 68 cents.